Related Experiment Video
Updated: Aug 14, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Patterns of Dyslipidemia Among Acute Coronary Syndrome (ACS) Patients at a Tertiary Care Hospital in Lahore, Pakistan
Muhammad Muneeb1, Ammar H Khan2, Attaullah Khan Niazi3
1Cardiology, Shalamar Medical and Dental College, Lahore, PAK.
Insights
Dyslipidemia, an abnormality in lipid levels, is highly prevalent in acute coronary syndrome (ACS) patients, affecting over 83%. This global cardiovascular disease risk factor was more common in males and those with ST-segment elevation myocardial infarction.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Dyslipidemia, characterized by abnormal lipid parameters, poses a significant global risk for cardiovascular diseases (CVDs).
- Understanding the prevalence and patterns of dyslipidemia in acute coronary syndrome (ACS) is crucial for risk stratification and management.
Purpose of the Study:
- To investigate the prevalence and specific patterns of dyslipidemia among patients diagnosed with acute coronary syndrome (ACS).
Main Methods:
- A cross-sectional study design was employed.
- Data were collected from 101 patients admitted with ACS to the critical care unit (CCU) / Rasheeda Begum Cardiac Centre (RBCC) over a 12-month period.
- Dyslipidemia was diagnosed based on abnormal lipid profile readings.
Main Results:
- The overall prevalence of dyslipidemia among ACS patients was high, at 83.2%.
- Dyslipidemia was more prevalent in male patients (65%) compared to female patients (34.5%).
- Prevalence varied by ACS type: 90.7% in ST-segment elevation myocardial infarction (STEMI), 80.6% in unstable angina (USA), and 74.1% in non-ST segment elevation myocardial infarction (NSTEMI).
Conclusions:
- A high prevalence of dyslipidemia exists within the ACS patient population.
- Obesity was also noted as a common comorbidity.
- Dyslipidemia was found to be more frequent in overweight individuals within this cohort.
Introduction:
Dyslipidemia refers to the presence of abnormalities in lipid parameters. It has become a global issue with a high risk of cardiovascular diseases (CVDs). The aim of the investigation was to find out the pattern and prevalence of dyslipidemia among patients with the acute coronary syndrome (ACS).
Methodology:
A cross-sectional study design was used. Data were collected using convenient sampling from 101 patients presenting with ACS, admitted at the critical care unit (CCU) / Rasheeda Begum Cardiac Centre (RBCC) of Shalamar Hospital, during a 12-month period from January 2020 to December 2021. Dyslipidemia is diagnosed by testing the lipid profile when there are one or more abnormal readings of the lipid profile.
Results:
Nearly 43 (42.6%) had ST-segment elevation myocardial infarction (STEMI), 27 (26.7%) had non-ST segment elevation myocardial infarction (NSTEMI), and 31 (30.7%) were categorized as unstable angina (USA). Overall dyslipidemia was present in 84 (83.2%) patients. The prevalence of dyslipidemia was 55 (65%) in male patients and 29 (34.5%) in female patients. Dyslipidemia was present in 39 (90.7%) patients with STEMI, 25 (80.6%) in the USA, and 20 (74.1%) with NSTEMI.
Conclusion:
The prevalence of dyslipidemia was quite high among ACS patients. The proportion of obese patients was also high in our study. However, dyslipidemia was more frequent in overweight patients.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Atherosclerosis I: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations

